Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|March 7, 2024
Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibitionWesam H Abdulaal, Hani Z Asfour, Nawal Helmi, et al.
Pharmaceutics|March 3, 2021
Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking StudiesMohammed W Al-Rabia, Nabil A Alhakamy, Osama A A Ahmed, et al.
Pharmaceutics|May 5, 2021
Piceatannol-Loaded Bilosome-Stabilized Zein Protein Exhibits Enhanced Cytostatic and Apoptotic Activities in Lung Cancer CellsNabil A Alhakamy, Giuseppe Caruso, Mohammed W Al-Rabia, et al.
International Immunopharmacology|February 25, 2024
Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in miceWesam H Abdulaal, Ulfat M Omar, Mustafa Zeyadi, et al.
Toxicology and Applied Pharmacology|July 17, 2024
Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-кB/TNF-α, and Wnt/GSK-3β/β-catenin signaling pathwaysWesam H Abdulaal, Ulfat M Omar, Mustafa Zeyadi, et al.
Biomaterials|February 10, 2019
Decellularised extracellular matrix-derived peptides from neural retina and retinal pigment epithelium enhance the expression of synaptic markers and light responsiveness of human pluripotent stem cell derived retinal organoidsBirthe Dorgau, Majed Felemban, Gerrit Hilgen, et al.
Pharmaceutics|May 31, 2020
Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo EvaluationUsama A Fahmy, Shaimaa M Badr-Eldin, Osama A A Ahmed, et al.
Pharmaceutics|February 24, 2024
RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485Usama A Fahmy, Shaimaa M Badr-Eldin, Osama A A Ahmed, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|April 29, 2024
Protective effect of kaempferol glucoside against lipopolysaccharide-caused acute lung injury via targeting Nrf2/NF-κB/NLRP3/GSDMD: Integrating experimental and computational studiesWesam H Abdulaal, Ulfat M Omar, Mustafa Zeyadi, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 23, 2024
Urolithin B as a renoprotective agent against 5-fluorouracil-induced nephrotoxicity: Role of Nrf2/Keap1/HO-1, SIRT1/FOXO3, and NF-кB/TNF-α signaling pathwaysMohammed W Al-Rabia, Hani Z Asfour, Rasha A Mansouri, et al.
Pageof 7